tiprankstipranks
Hikma Pharmaceuticals PLC (DE:H5P)
FRANKFURT:H5P
Germany Market

Hikma Pharmaceuticals (H5P) Technical Analysis

4 Followers

Summary of all the Indicators

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Hikma Pharmaceuticals PLC’s (H5P) Moving Averages Convergence Divergence (MACD) indicator is -0.27, suggesting Hikma Pharmaceuticals PLC is a Sell.
Hikma Pharmaceuticals PLC’s (H5P) 20-Day exponential moving average is 14.75, while Hikma Pharmaceuticals PLC’s (H5P) share price is €17.9, making it a Buy.
Hikma Pharmaceuticals PLC’s (H5P) 50-Day exponential moving average is 15.58, while Hikma Pharmaceuticals PLC’s (H5P) share price is €17.9, making it a Sell.

Hikma Pharmaceuticals (H5P) Pivot Points

Apr 06, 2026, 06:22 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
14.67
14.73
14.77
14.83
14.87
14.93
14.97
Fibonacci
14.73
14.77
14.80
14.83
14.87
14.90
14.93
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Hikma Pharmaceuticals (H5P) Moving Averages

Apr 06, 2026, 06:22 PM
Period
Simple
Exponential
MA5
14.70Buy
14.75Buy
MA10
14.60Buy
14.65Buy
MA20
14.32Buy
14.75Buy
MA50
15.96Sell
15.58Sell
MA100
16.64Sell
16.64Sell
MA200
18.52Sell
18.47Sell
Hikma Pharmaceuticals PLC’s (H5P) 10-Day exponential moving average is 14.65, while Hikma Pharmaceuticals PLC’s (H5P) share price is €17.9, making it a Buy.
Hikma Pharmaceuticals PLC’s (H5P) 100-Day exponential moving average is 16.64, while Hikma Pharmaceuticals PLC’s (H5P) share price is €17.9, making it a Sell.
Hikma Pharmaceuticals PLC’s (H5P) stock price is €17.9 and Hikma Pharmaceuticals PLC’s (H5P) 50-day simple moving average is 15.96, creating a Sell signal.
Hikma Pharmaceuticals PLC’s (H5P) stock price is €17.9 and Hikma Pharmaceuticals PLC’s (H5P) 100-day simple moving average is 16.64, creating a Sell signal.
Hikma Pharmaceuticals PLC’s (H5P) stock price is €17.9 and Hikma Pharmaceuticals PLC’s (H5P) 200-day simple moving average is 18.52, creating a Sell signal.

Hikma Pharmaceuticals (H5P) Technical Indicators

Apr 06, 2026, 06:22 PM
Name
Value
Implied Action
RSI (14)
49.41
Neutral
STOCH (9,6)
95.24
Sell
STOCHRSI (14)
56.44
Neutral
MACD (12,26)
-0.27
Sell
ADX (14)
19.99
Buy
Williams %R
-41.67
Buy
CCI (14)
77.71
Neutral
ATR (14)
0.48
-
Ultimate Oscillator
55.54
Neutral
ROC
6.41
Buy
Hikma Pharmaceuticals PLC’s (H5P) Relative Strength Index (RSI) is 49.41, creating a Neutral signal.
Hikma Pharmaceuticals PLC’s (H5P) Trend Strength Indicator (ADX) is 19.99, creating a Buy signal.
Hikma Pharmaceuticals PLC’s (H5P) Commodity Channel Index (CCI) is 77.71, creating a Neutral signal.
Hikma Pharmaceuticals PLC’s (H5P) Price Rate of Change (ROC) is 6.41, creating a Buy signal.

FAQ

Is H5P a Buy, Hold, or Sell?
Based on H5P’s technical indicators, H5P is a Hold.
    What is H5P’s RSI (14)?
    H5P’s RSI (14) is 49.41, which suggests H5P is a Neutral.
      What is H5P’s MACD?
      H5P’s MACD is -0.27, which suggests H5P is a Sell.
        What is H5P’s 5-day moving average?
        H5P’s 5-day moving average is 14.70, which suggests H5P is a Buy.
          What is H5P’s 20-day moving average?
          H5P 20-day moving average is 14.32, which suggests H5P is a Buy.
            What is H5P’s 50-day moving average?
            H5P’s 50-day moving average is 15.96, which suggests H5P is a Sell.
              What is H5P’s 200-day moving average?
              H5P’s 200-day moving average is 18.52, which suggests H5P is a Sell.
                What is H5P’s Williams % R (14)?
                H5P’s Williams % R (14) is -41.67, which suggests H5P is a Buy.
                  What is H5P’s CCI (14)?
                  H5P’s CCI (14) is 77.71, which suggests H5P is a Neutral.
                    What is the share price of Hikma Pharmaceuticals PLC?